Silo Pharma SILO
NASDAQ SILO
$1.51 -0.10 (-6.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Silo Pharma (SILO) Research & Development (2020 - 2026)

Updated

Silo Pharma's Research & Development was $298,418 in Q2 2026, down 58.4% from $717,247 a year earlier and down 70.5% from the prior quarter.

Analysis

Silo Pharma (SILO) Research & Development (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Silo Pharma's Research & Development was $2.16 million through Jun 30, 2026, down 25.6% year-over-year; for FY2025, it came in at $2.16 million, down 8.8% from FY2024.

  • Research & Development shows a five-year compound annual growth rate of 141.6% (FY2020 to FY2025).
  • In earlier years, Research & Development was $2.37 million in FY2024 (+180.2%), $845,092 in FY2023 (-34.3%), $1.29 million in FY2022 (+85.4%) and $693,910 in FY2021.
  • The Q2 2026 figure marks the lowest quarterly Research & Development since Q3 2023.
  • Compared with a year earlier, Research & Development was higher in six of the last eight quarters, with growth averaging 66.3%.
  • The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 432.9%); the worst was Q4 2025 (a decline of 71.6%).
  • Per Business Quant data, SILO's Research & Development in the three quarters before Q2 2026 was $1.01 million (Q1 2026), $306,005 (Q4 2025) and $543,615 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 3.65 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.34 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -4.05 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 993.80 Mn
10 Silo Pharma 1.82 Mn 1.82 Mn - 298,418.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 298,418.00
Mar 31, 2026 1.01 Mn
Dec 31, 2025 306,005.00
Sep 30, 2025 543,615.00
Jun 30, 2025 717,247.00
Mar 31, 2025 593,962.00
Dec 31, 2024 1.08 Mn
Sep 30, 2024 517,548.00
Jun 30, 2024 392,824.00
Mar 31, 2024 318,240.00
Dec 31, 2023 336,965.00
Sep 30, 2023 174,495.00
Jun 30, 2023 130,719.00
Mar 31, 2023 202,913.00
Dec 31, 2022 634,684.00
Sep 30, 2022 375,795.00
Jun 30, 2022 105,676.00
Mar 31, 2022 170,279.00
Dec 31, 2021 475,948.00
Sep 30, 2021 70,514.00
API Access

Silo Pharma Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=SILO&period=max&api_key=YOUR_API_KEY